These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7851161)

  • 41. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Male breast cancer. Histochemical and flow cytometry analysis of 6 cases].
    Galasso MG; Galia A; Gazzano G; Cosentino A; Castorina S
    Pathologica; 1995 Oct; 87(5):503-5. PubMed ID: 8868175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methodologies for the preservation of proliferation associated antigens PCNA, p120, and p105 in tumor cell lines for use in flow cytometry.
    Mikulka WR; Bolton WE
    Cytometry; 1994 Nov; 17(3):246-57. PubMed ID: 7851160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients.
    Niewiadomska H; Mirowski M; Stempien M; Olborski B; Blonski JZ; Hanausek M; Wierzbicki R
    Neoplasma; 1998; 45(4):216-22. PubMed ID: 9890664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
    Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
    J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation.
    Willett CG; Warland G; Coen J; Shellito PC; Compton CC
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):57-61. PubMed ID: 7721640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemoprevention.
    Risio M
    J Cell Biochem Suppl; 1994; 19():61-7. PubMed ID: 7823607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer.
    Lyzogubov V; Khozhaenko Y; Usenko V; Antonjuk S; Ovcharenko G; Tikhonkova I; Filonenko V
    Exp Oncol; 2005 Jun; 27(2):141-4. PubMed ID: 15995633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Proliferation-associated antigens PCNA and Ki-67 in two- and three-dimensional experimental systems of human squamous epithelial carcinomas].
    Knüchel R; Hofstaedter F; Sutherland RM; Keng PC
    Verh Dtsch Ges Pathol; 1990; 74():275-8. PubMed ID: 1708601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells.
    Landberg G; Roos G
    Cytometry; 1992; 13(3):230-40. PubMed ID: 1374305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ionic strength in immunocytochemical detection of the proliferation associated nuclear antigens p120, PCNA, and the protein reacting with Ki-67 antibody.
    Bruno S; Gorczyca W; Darzynkiewicz Z
    Cytometry; 1992; 13(5):496-501. PubMed ID: 1353016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Proliferative activity in gastric cancer with Ki-67 and propidium iodide: analysis by flow cytometry].
    Kimura H; Yonemura Y; Ohyama S; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):388-92. PubMed ID: 1603045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry.
    Paspatis GA; Karamanolis DG; Vasilakaki T; Zizi A; Xourgias V; Elemenoglou I; Hadziyannis SJ
    Am J Gastroenterol; 1995 Apr; 90(4):597-602. PubMed ID: 7717318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
    Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
    Ann N Y Acad Sci; 1993 Nov; 698():174-81. PubMed ID: 7904138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relationship between the Ki-67 nuclear antigen content and cell-cycle perturbation on WiDr cells treated with 5-FU].
    Tagawa Y; Kawazoe N; Sawai T; Yamaguchi S; Tomita M
    Hum Cell; 1993 Jun; 6(2):121-5. PubMed ID: 8217950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.